Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.47 |
| ▸ | PREP | P48147 | 6/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.40 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1340255 | 1.00 | DGAT1 (0.47) | DGAT1PREPTP53L3MBTL1CYP19A1 | |
| SCHEMBL7304447 | 0.87 | DGAT1 (0.58) | DGAT1PREPCYP19A1MAPTALDH1A1 | |
| SCHEMBL7292707 | 0.87 | DGAT1 (0.58) | DGAT1PREPCYP19A1MAPTALDH1A1 | |
| SCHEMBL3406500 | 0.87 | DGAT1 (0.58) | DGAT1PREPCYP19A1MAPTALDH1A1 | |
| SCHEMBL30612421 | 0.87 | DGAT1 (0.58) | DGAT1PREPCYP19A1MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL7389195 | 0.85 | DGAT1 (0.56) | DGAT1PREPCYP19A1MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL7393121 | 0.85 | DGAT1 (0.56) | DGAT1PREPCYP19A1MAPTALDH1A1 | |
| SCHEMBL11461276 | 0.84 | SIGMAR1 (0.52) | TP53L3MBTL1CYP19A1 | |
| SCHEMBL8732825 | 0.83 | AKR1B1 (0.39) | DGAT1PREPTP53L3MBTL1GAA | |
| SCHEMBL7072581 | 0.82 | SLC6A1 (0.43) | DGAT1PREP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110183330-B | Preparation method of 5, 6-diethyl-2, 3-dihydro-1H-indene-2-amine hydrochloride | 安徽华邦药业有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-119823001-A | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2025-04-15 | — | — | CN | disclosed |
| CN-114206832-B | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2025-04-04 | — | — | CN | disclosed |
| CN-116490499-A | Modulators of MYC family protooncogene proteins | 纳罗医疗公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-110914238-B | Compounds as antibiotics | 安塔比奥公司 | 2023-06-20 | — | — | CN | disclosed |
| EP-4048397-A1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS AND THERAPEUTIC METHODS USING THE SAME | The Regents Of The University Of Michigan (US) | 2022-08-31 | — | — | EP | disclosed |
| CN-110183330-B | Preparation method of 5, 6-diethyl-2, 3-dihydro-1H-indene-2-amine hydrochloride | 安徽华邦药业有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114206832-A | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2022-03-18 | — | — | CN | disclosed |